PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance.
Saved in:
| Title: | PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance. |
|---|---|
| Authors: | Jin H; Department of Respiratory Medicine, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China., Huang H; Department of Oncology, Zhenjiang Fourth People's Hospital, Zhenjiang, Jiangsu, China., Pan X; Zhenjiang 359 Hospital, Zhenjiang, Jiangsu, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 01; Vol. 17, pp. 1828765. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1828765 |
